A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention: Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study
- 17 September 2003
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 42 (6) , 1132-1139
- https://doi.org/10.1016/s0735-1097(03)01053-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary InterventionJAMA, 2003
- Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trialJournal of the American College of Cardiology, 2003
- Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: Results of the coronary revascularization using integrilin and single bolus enoxaparin studyJournal of the American College of Cardiology, 2003
- ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary articleJournal of the American College of Cardiology, 2002
- Low–molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: An expert consensus*American Heart Journal, 2002
- Defining the Optimal Activated Clotting Time During Percutaneous Coronary InterventionCirculation, 2001
- Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)Journal of the American College of Cardiology, 1996
- Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial InfarctionCirculation, 1996
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJournal of the American College of Cardiology, 1988
- Assay of heparin in plasma using a chromogenic substrate for activated factor XThrombosis Research, 1976